New CDER Deputy Director Michael Davis Brings Psychedelic Drug Development Experience

 
• By Sue Sutter
Psychedelic image
CDER's new deputy director has a background in psychedelic drug development. (Shutterstock)

More from US FDA

More from Agency Leadership